James McCracken, MD
| Dr. James McCracken is a distinguished Professor-in-Residence at UCSF’s Department of Psychiatry and Behavioral Sciences. He is widely recognized for his expertise in child and adolescent psychiatry, particularly in the use of pharmacological treatments for neurodevelopmental disorders such as ADHD, autism, OCD, and tic disorders. Dr. McCracken’s research is pioneering, especially in the field of pharmacogenetics, where he has been a national leader in studying how genetic differences influence responses to psychiatric medications in youth.
Before joining UCSF, Dr. McCracken was the Campbell Professor of Child Psychiatry at UCLA, where he directed the Division of Child and Adolescent Psychiatry. His work has garnered numerous accolades, including the American Psychiatric Association’s Blanche F. Ittleson Award, recognizing his outstanding contributions to child psychiatry research. Dr. McCracken is currently leading several major studies, including a $9-million NIH-funded project focused on developing new treatments for autism spectrum disorders. |
American Physician
